# Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

> **NCT01290692** · PHASE2 · COMPLETED · sponsor: **TVAX Biomedical** · enrollment: 14 (actual)

## Conditions studied

- Grade IV Glioma
- Grade IV Astrocytoma
- Glioblastoma Multiforme

## Interventions

- **BIOLOGICAL:** TVI-Brain-1

## Key facts

- **NCT ID:** NCT01290692
- **Lead sponsor:** TVAX Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290692, "Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01290692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*